Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Chip firm agrees $17.6bn buyout

RE: Chip firm agrees $17.6bn buyout

posted on Sep 18, 2006 08:42AM
Wow,

$584 million profit a year times 30 years = about the break even point. Don`t see right to me.

Share
New Message
Please login to post a reply